AI automatic diagnosis function for dog heart disease, unveiled for the first time at ‘New York Vet 2022’

• Signed domestic distribution contract with Green-Cross Veterinary Medicine
• Received the ‘Fressnapf Innovation Award 2022’, the highest authority for companion animals in Europe

Smartsound (CEO Lee, Jeong ho) officially launched ‘WITHaPET,’ an AI stethoscope for pets, in the global market at the ‘NewYork VET 2022’ held in the United States in early November. At this presentation, for the first time in the world, a function that can immediately check MMVD (Myxomatous Mitral Valve Disease), a heart disease that the majority of elderly dogs suffer from, in the early stage (B) with artificial intelligence AI-based auscultation was introduced for the first time in the world, and local academics and industry officials received great interest from

In addition, it received a high score for being able to have auscultation on the fur of a companion animal and auscultation of a newborn dog weighing less than 200g without rehairing. Smartsound plans to sign a contract with a leading local partner in the near future to determine a business model and sales price suitable for the US and global markets and start selling the product soon.

In addition, last October, it completed a domestic distribution contract with Green-Cross Veterinary Medicine, and won the Fressnapf Innovation Award 2022, the most prestigious innovation award for companion animals hosted by the ‘Fressnapf Group’, Europe’s largest pet product retailer have.

Since its establishment in 1973, Green-Cross Veterinary Medicine has been leading the animal drug market with various vaccines and treatments, and is also speeding up the development of the AI healthcare market. Germany’s Fressnapf Group has more than 1,400 dedicated stores and 8,000 employees in 12 European countries, and sales in 2021 are 4.3 trillion won.